טוען...
Gene therapies for high-grade gliomas: from the bench to the bedside
BACKGROUND: Gene therapy is the most attractive therapeutic approach against high-grade gliomas (HGGs). This is because of its theoretical capability to rework gene makeup in order to yield oncolytic effects. However, some factors still limit the upgrade of these therapies at a clinical level of evi...
שמור ב:
| הוצא לאור ב: | Acta Biomed |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mattioli 1885
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7975827/ https://ncbi.nlm.nih.gov/pubmed/32608374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23750/abm.v91i7-S.9953 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|